{"url_path":"/sec/jnj/8-k/2026-07-15/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of operations and financial condition","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/200406/0000200406-26-000146-index.html","accession_number":"0000200406-26-000146","cik":"0000200406","ticker":"JNJ","issuer_name":"JOHNSON & JOHNSON","edgar_url":"https://www.sec.gov/Archives/edgar/data/200406/0000200406-26-000146-index.html","primary_entity_key":"0000200406","primary_entity_name":"JOHNSON & JOHNSON"},"word_count":37,"has_tables":true,"body_markdown":"Item 2.02 Results of operations and financial condition\n\nOn July 15, 2026, Johnson & Johnson (the “Company”) issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the second quarter ended June 28, 2026."}